3rd Quarter - Amendment

HELIX, INC. for HELIX, INC.

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 3, 2022 $36,520 Replaced
3rd Quarter - Amendment (this page) Aug 3, 2023 $130,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to Human and Viral Genomic research, testing,funding and insurance coverage for hereditary cancer screening and treatment,opportunities for pharmacogenomic testing, pandemic preparedness, viral surveillance, and regulation of Lab Developed Tests.

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: Centers For Disease Control & Prevention (CDC); SENATE; HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

viral and human genomic research, testing,funding and insurance coverage, COVID-19 testing and research surveillance, sequencing and development of medical countermeasures for pathogens of pandemic potential Regulation Lab Developed Tests through VALID Act USH4128

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES New —

Contacted: Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Continued use of Covid Supplemental funding for viral surveillance, sequencing blood and spital samples, and PCR testing

LobbyistCovered position, as disclosed
KELLI ARTHUR HYKES —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.